Cathrin Skrabs

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Changes in cardiac parameters during venetoclax treatment.

Changes in cardiac parameters during venetoclax treatment.

Journal: Haematologica

Published: January 15, 2025

Persistent parvovirus B19 infection in a heavily pretreated lymphoma patient receiving mosunetuzumab.

Persistent parvovirus B19 infection in a heavily pretreated lymphoma patient receiving mosunetuzumab.

Journal: Leukemia & lymphoma

Published: September 24, 2024

Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus erythematosus and antiphospholipid syndrome.

Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus erythematosus and antiphospholipid syndrome.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 07, 2024

The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma.

The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma.

Journal: Frontiers in immunology

Published: July 27, 2022

The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies.

The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies.

Journal: Cancer medicine

Published: January 18, 2022

Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era.

Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era.

Journal: Cancers

Published: September 29, 2021

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Journal: Cancer discovery

Published: April 26, 2021

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.

Journal: European journal of haematology

Published: October 18, 2019

[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results.

[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results.

Journal: Investigative radiology

Published: April 12, 2018

Increased lymphocyte cell size with blastoid morphology associated with splenic rupture following cessation of ibrutinib.

Increased lymphocyte cell size with blastoid morphology associated with splenic rupture following cessation of ibrutinib.

Journal: British journal of haematology

Published: February 27, 2018

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.

Journal: Nature chemical biology

Published: November 15, 2017

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Journal: Blood

Published: October 13, 2017

Showing 1-12 of 30

Last Updated: 09/26/2026